MTRC Webinar: Joint Clinical Assessment of Medical Devices: What Do You Need to Know?

The EU Joint Clinical Assessment (JCA) introduces a mandatory, centralized scientific evaluation of selected high-risk medical devices and in-vitro diagnostic devices. It focuses on relative clinical effectiveness and relative safety, while decisions on pricing, reimbursement, cost-effectiveness, and funding remain the responsibility of individual Member States.  

MTRC invites MedTech professionals to an online seminar explaining the JCA process, its methodological requirements, and the practical implications for clinical development and evidence planning. 

During the seminar, we will discuss: 

• Which medical devices and IVDs may be selected for JCA;  
• Methodological requirements for JCA; 
• Specifics of the PICO requirements; 
• Practical steps manufacturers should take to prepare their evidence strategies.  

The seminar will be particularly relevant to professionals working in Market Access, HTA, HEOR, Clinical Development, Medical Affairs, Evidence Generation, Regulatory Affairs, and European launch planning. 

Speaker: Dr Oleg Borisenko, Founder and Director of MTRC 

Date and time: 17.00 CET, September 24, 2026 

Format: Online seminar. The seminar will not be recorded.  

Participation: Only representatives of the medical technology industry.  

You can register here.